Page 3 - Pascal Schmidt News Today

EQS-News: Marinomed Biotech AG / Key word: Quarter Results Marinomed Biotech AG reports best first quarter in company history 23.05.2023 / 07:45 CET/CEST The issuer is solely... | May 23, 2023

EQS-News: Marinomed Biotech AG / Key word(s): Quarter Results Marinomed Biotech AG reports best first quarter in company history ...

EQS-News: Marinomed Biotech AG / Key word(s): Annual ResultsMarinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023 19.04.2023 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement. Marinomed Biotech AG with Carragelose record sales in 2022and pos...

EQS-News: Marinomed Biotech AG / Key word(s): Preliminary ResultsMarinomed Biotech AG announces preliminary revenue for 2022 with double-digit growth for Carragelose 16.02.2023 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement. Marinomed Biotech AG announces preliminary reve...

EQS-News: Marinomed Biotech AG / Key word(s): PatentMarinomed Biotech AG: Marinomed Biotech receives US Patent approval for the Marinosolv® technology and invests in a series of new patents 27.12.2022 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement.Marinomed Biotech receives US...

EQS-News: Marinomed Biotech AG / Key word(s): Patent Marinomed Biotech AG: Marinomed Biotech receives US Patent approval for the Mari...

EQS-News: Marinomed Biotech AG / Key word(s): Quarter Results Marinomed Biotech AG reports increase in revenues for the first 9 month...

DGAP-News: Marinomed Biotech AG / Key word(s): Conference Marinomed to attend several upcoming investor and industry conferences ...

DGAP-News: Marinomed Biotech AG / Key word(s): Half Year Report Marinomed Biotech AG continues its growth path and reports strong fin...

DGAP-News: Marinomed Biotech AG / Key word(s): Agreement Marinomed to pause issuing of tranches of Convertible Notes Funding Program ...